DESCOVY contains 2 medicines: emtricitabine and tenofovir alafenamide (TAF)

DESCOVY® Co-pay and Insurance Support

The Gilead Advancing Access® program is committed to helping patients understand their insurance and obtain coverage for their treatment. Advancing Access is also available to help eligible patients afford their medication.

If eligible, Advancing Access is available to help with

  • Lowering co-pays and finding other independent co-pay support
  • Finding and understanding insurance
  • Prior authorization and resolving coverage benefits
Get Started With
Advancing Access

Register for DESCOVY® Information and Updates

If you would like to receive more information about DESCOVY, simply submit your contact information below.


*Please complete all required fields.

Terms and Conditions

Gilead respects the privacy of your personal information. Gilead, and companies providing services to Gilead, may use the information that you provide to send you marketing or informational materials, analyze and use your information to improve or develop services and programs, and contact you about marketing programs or research and health topics that may be of interest to you.

Gilead, and companies providing services to Gilead, will not sell or rent your personally identifiable information. For more information regarding our Privacy Policy, click here.

You are now leaving
Would you like to continue?